Oliver Blanchard
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS (NCT06249867) | Oliver Blanchard | 2024-11-08 |
Track Oliver Blanchard automatically
Every clearance here is in the API, with alerts when new ones post.